Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43424

CD248 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

CRISPR/Cas9-edited polyclonal CD248 knockout HAP1 cells offer a genetically disrupted model of endosialin, a transmembrane glycoprotein that binds fibronectin and collagen type I and triggers integrin-dependent activation of FAK and Src kinases. This signaling cascade drives MMP-mediated matrix remodeling and angiogenic responses, linking CD248 to tumor stroma expansion and fibrosis. Derived from a near-haploid chronic myeloid leukemia line, HAP1 cells maintain a fibroblastoid phenotype ideal for dissecting stromal cell biology. The polyclonal knockout population supports applications in cancer, angiogenesis, and fibrosis research using migration, adhesion, contraction, and phospho-signaling readouts.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    CD248

    Gene Identifier

    NCBI Gene ID 57124

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CD248 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional investigation of CD248 (endosialin) in a near-haploid human background. This product provides a genetically disrupted CD248 locus across a heterogenous pool of HAP1 cells, enabling robust loss-of-function studies without clonal selection. The polyclonal nature avoids clone-specific artifacts while preserving the convenience of a stable knockout model for biochemical and cell-based assays.

The HAP1 cell line originates from the chronic myeloid leukemia-derived KBM-7 line and retains a fibroblastoid, adherent morphology with a near-haploid karyotype of approximately 25 chromosomes. This simplified genetic landscape reduces functional redundancy and enhances the utility of the line for genetic screens, signaling pathway dissection, and drug-target validation. HAP1 cells are widely used in biomedical research due to their ease of culture and compatibility with high-throughput applications.

CD248 is a type I transmembrane glycoprotein that functions as a receptor for extracellular matrix components, including fibronectin and collagen type I. Engagement of CD248 promotes integrin ??2??1 clustering and activates focal adhesion kinase (FAK) and Src family kinases, leading to downstream phosphorylation of ERK/MAPK and AKT. These cascades transcriptionally upregulate matrix metalloproteinases such as MMP-2 and MMP-9, fostering pericellular proteolysis and cell migration. Upstream, CD248 expression is induced by TGF-??1, HIF-1??, Wnt3a, and PDGF-BB, situating it at the intersection of fibrotic, hypoxic, and angiogenic signaling networks.

In the HAP1 fibroblastoid context, CD248 disruption provides a physiologically relevant platform to study stromal contributions to tumor progression and tissue remodeling. The near-haploid genome minimizes off-target effects and facilitates straightforward interpretation of phospho-signaling changes measured by immunoblotting. As HAP1 cells exhibit constitutive adhesion and migration properties, the knockout population is particularly suited for dissecting integrin-mediated mechanotransduction without the confounding influence of aneuploidy-driven signaling variability.

Applications include western blotting for CD248 protein verification, RT-qPCR for transcript confirmation, and immunofluorescence to assess localization changes upon gene disruption. Functional assays such as scratch-wound migration, cell adhesion to fibronectin- or collagen-coated surfaces, and collagen gel contraction can quantify the contribution of CD248 to matrix remodeling. Co-culture angiogenesis assays and gelatin zymography for MMP activity further extend the model to vascular biology. Phospho-FAK immunoblotting and flow cytometry for surface integrins allow detailed pathway analysis. For additional technical information or to explore custom assay configurations, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)